At Boehringer Ingelheim, we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.

Scientists, researchers, practicing veterinarians, animal health companies and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.

At Boehringer Ingelheim, we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.

2016 Equine Research Award Recipients Announced
The awards were announced at the recent American Association of Equine Practitioners Annual Convention in Orlando, FL. Each researcher received a grant of $15,000 in support of their study proposal.

The BIVI Equine Research Award will focus on one specific equine disease area each year. For 2017, the equine disease of focus is equine infectious disease. 

Proposals must address one or more specific criteria to be considered:

  • Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)
  • Disease(s) can be bacterial or viral etiologies

Contact Us

  • The Advancement in Equine Research Award

    Boehringer Ingelheim 
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506

Proposals Due 

The deadline for proposals for the 2017 Advancement in Equine Research Award is: September 15, 2017

Submit Your Proposal To:

  • The 2017 Advancement in Equine Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506

    Mark the envelope “The Advancement in Equine Research Award”